Ampio Pharmaceuticals AMPE
$ 0.62
-11.43%
Annual report 2023
added 03-27-2024
Ampio Pharmaceuticals Balance Sheet 2011-2024 | AMPE
Annual Balance Sheet Ampio Pharmaceuticals
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-12 M | -33 M | -16.1 M | -5.06 M | -7.59 M | -8.21 M | -4.89 M | -22 M | -50.3 M | -26.3 M | -17.7 M | -11.4 M | |
Long Term Debt |
- | 274 K | 614 K | - | - | - | - | - | 4.92 M | - | - | - | - |
Long Term Debt Current |
274 K | 340 K | 311 K | 284 K | 259 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 3.53 M | 3.27 M | 7.41 M | 45.6 M | 4.83 M | 6.98 M | 1.13 M | 331 K | 381 K | 431 K |
Total Current Liabilities |
2.38 M | 1.19 M | 5.12 M | 1.83 M | 4.28 M | 1.38 M | 3.88 M | 2.13 M | 5.52 M | 3.68 M | 2.47 M | 1.64 M | 1.29 M |
Total Liabilities |
2.38 M | 1.8 M | 11.5 M | 5.37 M | 7.56 M | 8.79 M | 49.5 M | 6.96 M | 12.5 M | 4.81 M | 2.8 M | 2.02 M | 1.72 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | 85.7 K | 85.7 K | 50 K | 50 K | 50 K |
Retained Earnings |
-243 M | -234 M | -218 M | -201 M | -185 M | -171 M | -205 M | -153 M | -134 M | -102 M | -63.8 M | -39.8 M | -28.2 M |
Total Assets |
5.74 M | 13.6 M | 38.8 M | 22.9 M | 14 M | 14 M | 15.3 M | 13.6 M | 50.4 M | 70.3 M | 36 M | 25.8 M | 19.5 M |
Cash and Cash Equivalents |
4.09 M | 12.7 M | 33.9 M | 17.3 M | 6.53 M | 7.59 M | 8.21 M | 4.89 M | 16 M | 50.3 M | 26.3 M | 17.7 M | 11.4 M |
Book Value |
3.36 M | 11.8 M | 27.3 M | 17.5 M | 6.44 M | 5.24 M | -34.2 M | 6.63 M | 37.9 M | 65.5 M | 33.2 M | 23.8 M | 17.8 M |
Total Shareholders Equity |
3.36 M | 11.8 M | 27.3 M | 17.5 M | 6.44 M | 5.24 M | -34.2 M | 6.63 M | 37 M | 66.1 M | 33.1 M | 23.8 M | 17.8 M |
All numbers in USD currency
Quarterly Balance Sheet Ampio Pharmaceuticals
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 94 K | 185 K | 274 K | 362 K | 448 K | 533 K | 614 K | 694 K | 773 K | 851 K | 925 K | 925 K | 925 K | 925 K | 1.21 M | 1.28 M | 1.21 M | 1.21 M | 477 K | - | 477 K | 477 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.27 M | 2.59 M | 2.86 M | 1.8 M | 4.99 M | 7.12 M | 10.5 M | 11.5 M | 5.2 M | 6.35 M | 4.95 M | 5.37 M | 5.37 M | 5.37 M | 5.37 M | 7.56 M | 7.56 M | 7.56 M | 7.56 M | 8.79 M | 8.79 M | 8.79 M | 8.79 M | 49.5 M | 49.5 M | 49.5 M | 49.5 M | 6.96 M | 6.96 M | 6.96 M | 6.96 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 4.81 M | 4.81 M | 4.81 M | 4.81 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.02 M | 2.02 M | 2.02 M | 2.02 M | 1.72 M | 1.72 M | 1.72 M | 1.72 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 85.7 K | 85.7 K | 85.7 K | 85.7 K | 85.7 K | 85.7 K | 85.7 K | 85.7 K | 50 K | 50 K | 50 K | 50 K | 50 K | 50 K | 50 K | 50 K | 50 K | 50 K | 50 K | 50 K |
Retained Earnings |
-240 M | -239 M | -238 M | -234 M | -232 M | -225 M | -223 M | -218 M | -211 M | -208 M | -204 M | -201 M | -201 M | -201 M | -201 M | -185 M | -185 M | -185 M | -185 M | -171 M | -171 M | -171 M | -171 M | -205 M | -205 M | -205 M | -205 M | -153 M | -153 M | -153 M | -153 M | -134 M | -134 M | -134 M | -134 M | -102 M | -102 M | -102 M | -102 M | -63.8 M | -63.8 M | -63.8 M | - | - | - | - | - | - | - | - | - |
Total Assets |
7.65 M | 9.15 M | 10.7 M | 13.6 M | 18.8 M | 27.2 M | 32.8 M | 38.8 M | 22.5 M | 26.7 M | 21.7 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 14 M | 14 M | 14 M | 14 M | 14 M | 14 M | 14 M | 14 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 70.3 M | 70.3 M | 70.3 M | 70.3 M | 36 M | 36 M | 36 M | 36 M | 25.8 M | 25.8 M | 25.8 M | 25.8 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M |
Cash and Cash Equivalents |
6.4 M | 6.95 M | 10.4 M | 12.7 M | 16.9 M | 22.9 M | 28.8 M | 33.9 M | 17.1 M | 20.5 M | 15.8 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 6.53 M | 6.53 M | 6.53 M | 6.53 M | 7.58 M | 7.59 M | 7.59 M | 7.59 M | 8.21 M | 8.21 M | 8.21 M | 8.21 M | 4.89 M | 4.89 M | 4.89 M | 4.89 M | 27 M | 16 M | 16 M | 16 M | 50.3 M | 50.3 M | 50.3 M | 50.3 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M |
Book Value |
5.38 M | 6.56 M | 7.88 M | 11.8 M | 13.8 M | 20.1 M | 22.3 M | 27.3 M | 17.3 M | 20.4 M | 16.8 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | 6.44 M | 6.44 M | 6.44 M | 6.44 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | -34.2 M | -34.2 M | -34.2 M | -34.2 M | 6.63 M | 6.63 M | 6.63 M | 6.63 M | 37.9 M | 37.9 M | 37.9 M | 37.9 M | 65.5 M | 65.5 M | 65.5 M | 65.5 M | 33.2 M | 33.2 M | 33.2 M | 33.2 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M |
Total Shareholders Equity |
5.38 M | 6.56 M | 7.88 M | 11.8 M | 13.8 M | 20.1 M | 22.3 M | 27.3 M | 17.3 M | 20.3 M | 16.8 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | 6.44 M | 6.44 M | 6.44 M | 6.44 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | -34.2 M | -34.2 M | -34.2 M | 5 M | 6.63 M | 9.77 M | 13.1 M | 17.9 M | 37 M | 37 M | 37 M | 37 M | 66.1 M | 66.1 M | 66.1 M | 66.1 M | 33.1 M | 33.1 M | 33.1 M | 33.1 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M |
All numbers in USD currency